Feed Preview

Fast Growing

Stem Cells in Neurodegenerative Diseases

Stem Cells in Neurodegenerative Diseases diagram by Shengxiu Li et al
Shengxiu Li et al

Stem cells have the potential to develop into many different types of cells in the body and may be useful as a therapy for several diseases including neurodegenerative diseases. Discover the latest research on stem cells and neurodegenerative diseases here.

Top 20 most recent papers
Stroke; a Journal of Cerebral Circulation

Global Burden of Small Vessel Disease-Related Brain Changes on MRI Predicts Cognitive and Functional Decline

Stroke; a Journal of Cerebral CirculationNovember 8, 2019
Hanna JokinenTimo J Erkinjuntti
8
Stem Cell Research

Generation of an induced pluripotent stem cell line (EURACi005-A) from a Parkinson's disease patient carrying a homozygous exon 3 deletion in the PRKNgene

Stem Cell ResearchOctober 25, 2019
Alessandra ZanonIrene Pichler
2
The Journal of Clinical Investigation

Human Autologous iPSC-Derived Dopaminergic Progenitors Restore Motor Function in Parkinson's Disease Models

The Journal of Clinical InvestigationNovember 12, 2019
Bin SongKwang-Soo Kim
1
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry

Neurocognitive Effects of Combined Electroconvulsive Therapy (ECT) and Venlafaxine in Geriatric Depression: Phase 1 of the PRIDE Study

The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric PsychiatryOctober 12, 2019
Sarah Hollingsworth LisanbyCORE/PRIDE Work Group
3
1
JAMA Neurology

Reactions to Multiple Ascending Doses of the Microtubule Stabilizer TPI-287 in Patients With Alzheimer Disease, Progressive Supranuclear Palsy, and Corticobasal Syndrome: A Randomized Clinical Trial

JAMA NeurologyNovember 11, 2019
Richard M TsaiAdam L. Boxer
14
1
Multiple Sclerosis Journal - Experimental, Translational and Clinical

Serum neurofilament light chain concentration in a phase 1/2 trial of autologous mesenchymal stem cell transplantation

Multiple Sclerosis Journal - Experimental, Translational and ClinicalNovember 5, 2019
Laura E BaldassariJeffrey Allen Cohen
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience

Hippocampal neurogenesis and neural circuit formation in a cuprizone-induced multiple sclerosis mouse model

The Journal of Neuroscience : the Official Journal of the Society for NeuroscienceNovember 12, 2019
Hai ZhangHoonkyo Suh
Proceedings of the National Academy of Sciences of the United States of America

Multistable properties of human subthalamic nucleus neurons in Parkinson's disease

Proceedings of the National Academy of Sciences of the United States of AmericaNovember 11, 2019
Jeremy W ChopekRobert M Brownstone
2
Journal of Acquired Immune Deficiency Syndromes : JAIDS

Exosomal MicroRNAs Associate With Neuropsychological Performance in Individuals With HIV Infection on Antiretroviral Therapy

Journal of Acquired Immune Deficiency Syndromes : JAIDSNovember 13, 2019
Tess OʼMearaLin-Geng Lu
Epigenetics & Chromatin

Chromatin accessibility and transcription dynamics during in vitro astrocyte differentiation of Huntington's Disease Monkey pluripotent stem cells

Epigenetics & ChromatinNovember 13, 2019
Alexandra V GoodnightAnthony Wing Sang Chan
Neuroscience and Biobehavioral Reviews

NEUROCOGNITIVE CONSEQUENCES OF CHRONIC CANNABIS USE: A SYSTEMATIC REVIEW AND META-ANALYSIS

Neuroscience and Biobehavioral ReviewsNovember 9, 2019
Pedro Cardoso FigueiredoAlexander Baldacchino
8
Orphanet Journal of Rare Diseases

The attenuated end of the phenotypic spectrum in MPS III: from late-onset stable cognitive impairment to a non-neuronopathic phenotype

Orphanet Journal of Rare DiseasesNovember 12, 2019
Stephanie C M NijmeijerMargreet A E M Wagenmakers
NeuroImage. Clinical

Prediction of sleep side effects following methylphenidate treatment in ADHD youth

NeuroImage. ClinicalOctober 21, 2019
Jae Hyun YooNeal D Ryan
Molecules and Cells

ApoE4-Induced Cholesterol Dysregulation and Its Brain Cell Type-Specific Implications in the Pathogenesis of Alzheimer's Disease

Molecules and CellsNovember 12, 2019
Woo-Jin JeongJin-Soo Seo
1
Neuropsychologia

Three-systems for visual numerosity: A single case study

NeuropsychologiaNovember 11, 2019
Giovanni AnobileGuido Marco Cicchini
Harvard Review of Psychiatry

Double-Dissociation Studies in Psychiatric Research: A Scoping Review

Harvard Review of PsychiatryNovember 13, 2019
Can Misel Kilciksiz, Dost Ongür
FEBS Letters

Next-generation disease modeling with direct conversion: A new path to old neurons

FEBS LettersNovember 12, 2019
Larissa TraxlerJerome Mertens
1
International Journal of Environmental Research and Public Health

Causal Effects of Prenatal Exposure to PM2.5 on Child Development and the Role of Unobserved Confounding

International Journal of Environmental Research and Public HealthNovember 9, 2019
Viola TozziMichela Baccini
Epilepsy & Behavior : E&B

Temporal lobe surgery and memory: Lessons, risks, and opportunities

Epilepsy & Behavior : E&BNovember 8, 2019
Kristie BaumanAnli A Liu
8
Journal of Neuro-oncology

Delay in diagnosing patients with right-sided glioblastoma induced by hemispheric-specific clinical presentation

Journal of Neuro-oncologyNovember 11, 2019
Claudia BaumannChristian Foerch

See more papers from this feed

Related Feeds

ALS

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.

ALS & FTD: TDP-43

ALS shares with a considerable proportion of FTD cases the same neuropathological substrate, namely, inclusions of abnormally phosphorylated protein tdp-43 (ptdp-43). Here are the latest discoveries pertaining to ptdp-43 and these diseases.

ALS - Pathogenic Mechanisms

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS - Phenotypes

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating phenotypes associated with this genetically heterogeneous disorder.

ALS: Genetics

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here are the latest discoveries pertaining to this disease.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS therapies here.

ALS: Transposon de-silencing

Transposon silencing is a form of transcriptional gene silencing. These gene silencing mechanisms are impaired in Amyotrophic lateral sclerosis (ALS). Here are the latest discoveries pertaining to transposon silencing and this disease.

Adult Stem Cells

Adult stem cells reside in unique niches that provide vital cues for their survival, self-renewal, and differentiation. They hold great promise for use in tissue repair and regeneration as a novel therapeutic strategies. Here is the latest research.

© 2019 Meta ULC. All rights reserved
/feed-previews/stem-cells-in-neurodegenerative/eb7df63c-93a6-4753-a40e-b95572ef94b2